Royal KPN N.V.:企業のM&A・事業提携・投資動向

◆英語タイトル:Royal KPN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2311
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:137
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Royal KPN N.V. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Royal KPN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Royal KPN N.V. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Royal KPN N.V.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Royal KPN N.V.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Royal KPN N.V.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Royal KPN N.V. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Royal KPN N.V.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Royal KPN N.V.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 69
Partnership – Deal reports 69
DIVESTMENTS 77
Divestments – Overview 77
Divestments – Deal reports 78
PRIVATE EQUITY & OWNERSHIP 117
Private Equity and Ownership – Deal reports 117
APPENDIX 127
Contact Us 127
About MarketLine Financial Deals Database 127
Deal Definition and Methodology 129
About MarketLine 136

List of Tables
Table 1: Royal KPN N.V. M&A volume and value trend (2014-YTD2018)
Table 2: Royal KPN N.V. M&A activity by geography (2014-YTD2018)
Table 3: Royal KPN N.V. divestments volume and value trend (2014-YTD2018)
Table 4: Royal KPN N.V. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Royal KPN N.V. M&A volume and value trend (2014-YTD2018)
Figure 2: Royal KPN N.V. M&A activity by geography (2014-YTD2018)
Figure 3: Royal KPN N.V. divestments volume and value trend (2014-YTD2018)
Figure 4: Royal KPN N.V. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Royal KPN N.V.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ventana Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • PICC Property and Casualty Company Limited:戦略・SWOT・企業財務分析
    PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that provides generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is …
  • Editas Medicine Inc (EDIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Editas Medicine Inc (Editas Medicine) formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its in-licensed clustered regularly interspaced short palin …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Leukocare AG:医療機器:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • New York Power Authority:企業の戦略・SWOT・財務情報
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Biocartis Group NV (BCART):企業の製品パイプライン分析
    Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology a …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aura Light International AB:企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Echosens SA:医療機器:M&Aディール及び事業提携情報
    Summary Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd, is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers fibrometer, fibroscan, fibro …
  • ADX Energy Ltd (ADX):石油・ガス:M&Aディール及び事業提携情報
    Summary ADX Energy Ltd (ADX) is an upstream oil and gas company that carries out energy exploration activities in North Africa and Europe. The company operates through three segments, namely, Tunisia Exploration and Evaluation, Romania Exploration and Evaluation and Italy Exploration and Evaluation. …
  • Questerre Energy Corp (QEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Aksa Enerji Uretim AS (AKSEN):電力:M&Aディール及び事業提携情報
    Summary Aksa Enerji Uretim A.S. (Aksa Enerji), a subsidiary of Kazanci Holding A.S., is an independent power generation company. The company produces electricity through natural gas, fuel oil, hydro and wind power plants. Apart from power generation and sale, it also provides services such as projec …
  • Armada Hoffler Properties Inc:企業の戦略・SWOT・財務分析
    Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Armada Hoffler Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Atos SE:企業の戦略・SWOT・財務情報
    Atos SE - Strategy, SWOT and Corporate Finance Report Summary Atos SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • bioMerieux Inc-医療機器分野:企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆